Aberdeen Wealth Management »

Crispr Therapeutics shares owned by Aberdeen Wealth Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Aberdeen Wealth Management from 13F filings

Historical chart of Aberdeen Wealth Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Aberdeen Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Aberdeen Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $115k 2.1k 54.54

More positions owned by Aberdeen Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Admiral Fds Midcp 400 Val (IVOV)
Schwab Strategic Tr Fundamental Us L (FNDX)
Applied Materials (AMAT)
Apple (AAPL)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Bd Index Fds Vanguard Ultra (VUSB)
NVIDIA Corporation (NVDA)
Abbvie (ABBV)
Microsoft Corporation (MSFT)
Ishares Tr Select Divid Etf (DVY)

View all positions for Aberdeen Wealth Management

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics